Grandfield & Dodd, LLC Merck & Co., Inc. Transaction History

Grandfield & Dodd, LLC

  • $1.49 Billion
  • Q2 2024

A detailed history of Grandfield & Dodd, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 294,877 shares of MRK stock, worth $32.4 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares
294,877
Previous 305,379 3.44%
Holding current value
$32.4 Million
Previous $40.3 Million 9.4%
% of portfolio
2.45%
Previous 2.68%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$123.8 - $132.96 $1.3 Million - $1.4 Million
-10,502 Reduced 3.44%
294,877 $36.5 Million
Q1 2024

May 03, 2024
SELL
$113.24 - $131.95 $188,997 - $220,224
-1,669 Reduced 0.54%
305,379 $40.3 Million
Q4 2023

Jan 31, 2024
SELL
$100.18 - $109.02 $45,081 - $49,059
-450 Reduced 0.15%
307,048 $33.5 Million
Q3 2023

Oct 25, 2023
SELL
$102.95 - $114.33 $162,352 - $180,298
-1,577 Reduced 0.51%
307,498 $31.7 Million
Q2 2023

Aug 07, 2023
SELL
$108.61 - $118.38 $355,371 - $387,339
-3,272 Reduced 1.05%
309,075 $35.7 Million
Q1 2023

Apr 28, 2023
SELL
$102.94 - $114.86 $130,630 - $145,757
-1,269 Reduced 0.4%
312,347 $33.2 Million
Q4 2022

Jan 20, 2023
BUY
$87.44 - $112.11 $70,651 - $90,584
808 Added 0.26%
313,616 $0
Q3 2022

Nov 03, 2022
BUY
$84.53 - $94.96 $197,631 - $222,016
2,338 Added 0.75%
312,808 $26.9 Million
Q2 2022

Aug 01, 2022
SELL
$83.49 - $94.64 $25,297 - $28,675
-303 Reduced 0.1%
310,470 $28.3 Million
Q1 2022

Apr 19, 2022
SELL
$73.51 - $82.4 $69,613 - $78,032
-947 Reduced 0.3%
310,773 $25.5 Million
Q4 2021

Feb 08, 2022
BUY
$72.28 - $90.54 $176,435 - $221,008
2,441 Added 0.79%
311,720 $23.9 Million
Q3 2021

Oct 28, 2021
SELL
$71.68 - $78.83 $306,360 - $336,919
-4,274 Reduced 1.36%
309,279 $23.2 Million
Q2 2021

Jul 28, 2021
BUY
$70.31 - $77.77 $504,193 - $557,688
7,171 Added 2.34%
313,553 $24.4 Million
Q1 2021

Apr 22, 2021
SELL
$68.86 - $81.11 $63,626 - $74,945
-924 Reduced 0.3%
306,382 $23.6 Million
Q4 2020

Jan 29, 2021
BUY
$71.77 - $79.65 $57,200 - $63,481
797 Added 0.26%
307,306 $25.1 Million
Q3 2020

Nov 03, 2020
SELL
$73.18 - $82.95 $46,176 - $52,341
-631 Reduced 0.21%
306,509 $25.4 Million
Q2 2020

Jul 24, 2020
SELL
$70.42 - $80.13 $96,757 - $110,098
-1,374 Reduced 0.45%
307,140 $23.8 Million
Q1 2020

May 14, 2020
SELL
$63.36 - $87.82 $338,849 - $469,661
-5,348 Reduced 1.7%
308,514 $23.7 Million
Q4 2019

Feb 07, 2020
BUY
$77.58 - $87.54 $17,222 - $19,433
222 Added 0.07%
313,862 $28.5 Million
Q3 2019

Oct 30, 2019
SELL
$76.08 - $82.93 $50,897 - $55,480
-669 Reduced 0.21%
313,640 $26.4 Million
Q2 2019

Jul 29, 2019
SELL
$69.84 - $81.59 $1.05 Million - $1.23 Million
-15,081 Reduced 4.58%
314,309 $26.4 Million
Q1 2019

Apr 26, 2019
SELL
$69.58 - $79.36 $375,453 - $428,226
-5,396 Reduced 1.61%
329,390 $27.4 Million
Q4 2018

Feb 12, 2019
SELL
$65.24 - $75.71 $205,571 - $238,562
-3,151 Reduced 0.93%
334,786 $25.6 Million
Q3 2018

Nov 02, 2018
SELL
$57.69 - $67.84 $54,805 - $64,448
-950 Reduced 0.28%
337,937 $24 Million
Q2 2018

Jul 27, 2018
SELL
$50.83 - $59.72 $6,353 - $7,465
-125 Reduced 0.04%
338,887 $20.6 Million
Q1 2018

May 04, 2018
SELL
$50.96 - $59.23 $268,559 - $312,142
-5,270 Reduced 1.53%
339,012 $18.5 Million
Q4 2017

Feb 06, 2018
BUY
$51.62 - $61.64 $34,017 - $40,620
659 Added 0.19%
344,282 $19.4 Million
Q3 2017

Nov 03, 2017
BUY
$58.67 - $63.13 $20.2 Million - $21.7 Million
343,623
343,623 $22 Million

Others Institutions Holding MRK

# of Institutions
3,826
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email